ROW Foundation - Narrowing epilepsy treatment gaps

Epilepsy is a global problem that deserves a global solution.™ 🌎

Most people with epilepsy in high-income countries achieve seizure control, but epilepsy care isn't common in the rest of the world. Globally, some 40 million people live with untreated epilepsy because they can't access treatments available in countries like the U.S. We believe everyone should receive the same level of care for their epilepsy, no matter where they live!

ROW (“Rest of World") Foundation is the social enterprise partner of OWP Pharmaceuticals, a U.S. marketer of epilepsy and psychiatric medications. OWP profits and medication donations plus donor support fuel the work of ROW. 

Through global partnerships, we narrow treatment gaps in low- and middle-income countries with:
 ▫️Healthcare provider training
 ▫️EEG & telemedicine
 ▫️Anti-seizure medications

Since 2015, we've partnered with 68 organizations to improve epilepsy care in 33 countries, and we're just getting started!